Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies (Q37941160)

25 August 2017

1 reference

title

Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies (English)

1 reference

25 August 2017

1 reference

1 reference

Eduardo L Franco

5

0 references

author name string

Joseph E Tota

1

1 reference

25 August 2017

Myriam Chevarie-Davis

2

1 reference

25 August 2017

Lyndsay A Richardson

3

1 reference

25 August 2017

Maaike Devries

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

53 Suppl 1

1 reference

25 August 2017

S12-21

1 reference

A stratified approach to untangling the behavioral/biomedical outcomes conundrum

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Trends of cervical cancer mortality in the member states of the European Union

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Worldwide burden of cervical cancer in 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

The epidemiology of human papillomavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Carrageenan is a potent inhibitor of papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

The male role in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Beyond cervical cancer: burden of other HPV-related cancers among men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Six-month natural history of oral versus cervical human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Case-control study of human papillomavirus and oropharyngeal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Oral sexual behaviors associated with prevalent oral human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Prevalence of HPV infection among females in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Sexual behaviour: related adverse health burden in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Transmission of Cervical Human Papillomavirus Infection by Sexual Activity: Differences between Low and High Oncogenic Risk Types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Current topics in the epidemiology of oral cavity and oropharyngeal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Anal human papillomavirus infection in women and its relationship with cervical infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Transmission of Human Papillomavirus in Heterosexual Couples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Persistence of type-specific human papillomavirus infection among cytologically normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Natural history of cervicovaginal papillomavirus infection in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Declining death rates reflect progress against cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Epidemiology of genital human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Determinants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Epidemiology of HPV infection among Mexican women with normal cervical cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Partner type and condom use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Polymorphisms of the Human Leukocyte Antigen DRB1 and DQB1 Genes and the Natural History of Human Papillomavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Multiple human papilloma virus types in cervical infections: competition or synergy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Cervical Coinfection with Human Papillomavirus (HPV) Types and Possible Implications for the Prevention of Cervical Cancer by HPV Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

The spectrum and clinical sequelae of human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Financing HPV vaccination in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus prevalence and type distribution in male anogenital sites and semen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

The global health burden of infection-associated cancers in the year 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

For cancers caused by HPV, two vaccines were just the beginning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Determinants of Low-Risk and High-Risk Cervical Human Papillomavirus Infections in Montreal University Students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Occurrence of Cervical Infection with Multiple Human Papillomavirus Types is Associated with Age and Cytologic Abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

HPV screening for cervical cancer in rural India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus testing in the prevention of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Viral load as a predictor of the risk of cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Age-specific prevalence of human papillomavirus infection in males: a global review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Detection of human papillomavirus DNA on the fingers of patients with genital warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Concurrent and sequential acquisition of different genital human papillomavirus types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Condom use and the risk of genital human papillomavirus infection in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

Prospects for controlling cervical cancer at the turn of the century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2011.08.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YPMED.2011.08.017

1 reference

25 August 2017

1 reference